Platelet and plasma vasoactive amine concentrations were measured in healthy controls and in type 1 (insulin-dependent) diabetic patients with or without vascular disease. Platelet concentrations of serotonin and noradrenaline were similar in all groups and were unrelated to age or gender, or to duration of diabetes, blood pressure, glycaemia or renal function in the diabetic subjects. Plasma concentrations of serotonin in the diabetic groups were comparable (118 ± 16 (mean ± SEM) and 127 ± 21 pmol/mL), and were significantly higher in comparison to the healthy controls (66 ± 12 pmol/mL, P = 0·002).
JenningsPEBarnettAH. New approaches to the pathogenesis and treatment of diabetic microangiopathyDiabetic Med1985; 5: 111–7.
3.
ColwellJAWinocourPDHalushkaOV. Do platelets have anything to do with diabetic microvascular disease?Diabetes1983; 21 (Suppl 2): 14–9.
4.
ColwellJAHalushkaPVSarjiKESagelJ.Platelet function and diabetes mellitus. Med Clin North Am1978; 62: 753–6.
5.
ColwellJASagelJCrookLChambersALaminsM.Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with and without vascular disease. Metabolism1977; 26: 279–85.
6.
PetersonCMJonesRLKoenigRJMelvinETLehrmanML. Reversible haematologic sequelae of diabetes mellitus. Ann Intern Med1977; 86: 425–9.
7.
LeccrubierCScarabinPYGraysoFSamamaM.Platelet aggregation related to age in diabetes mellitus. Haemostasis1980; 9: 43–8.
8.
JonesRLParadiseCPetersonCM. Platelet survival in patients with diabetes mellitus. Diabetes1981; 30: 486–9.
9.
HametPSugimotoHImeraRAbnormalities of platelet derived growth factor in insulin-dependent diabetes. Metabolism1985; 34 (Suppl 1): 25–31.
PetersenHDGormsenJ.Platelet aggregation in diabetes mellitus. Acta Med Scand1978; 203: 125–30.
13.
CollierAWatsonHHKMatthewsDMStrainLLudlamCAClarkBF. Platelet-density analysis and intraplatelet granule content in young insulin-dependent diabetics. Diabetes1986; 35: 1081–4.
14.
CollierATymkewyczPArmstrongRYoungRJJonesLClarkeBF. Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy. Diabetologia1986; 29: 471–4.
15.
SchachterMGrahame-SmithDG. 5-Hydroxytryptamine and the platelet: Specific binding and active uptake. In: VanhouttePMde ClerckF, eds. 5-hydroxytryptamine in peripheral reactions. New York: Raven Press, 1982: 49–59.
16.
VanhouttePM. 5-hydroxytryptamine, vasospasm, and hypertension. In: VanhouttePMde ClerckF, eds. 5-Hydroxytryptamine in peripheral reactions. New York: Raven Press, 1982: 163–74.
17.
PortaMLa SelvaMMolinattiGM. Endothelial cell function in diabetic macroangiopathy. Diabetologia1987; 30: 601–9.
18.
EwingDJClarkeBF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J1982; 285: 916–8.
19.
MenysVCDaviesJA. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets. Clin Sci1983; 65: 149–53.
20.
GrennanAKlimiukPWeincoveC.The measurement of platelet serotonin by HPLC. Ann Clin Biochem1988; 25 (Suppl): 192–3.
21.
HughDGrennanAAbugilaMAWeinkoveC.Ascorbic acid as an antioxidant in measurements of catecholamines in plasma. Clin Chem1987; 33: 569–71.
22.
GillDSBarradasMAFonsecaVAGraceyLDandonaP.Increased histamine content in leucocytes and platelets of patients with peripheral vascular disease. Am J Clin Pathol1988; 89: 622–6.
23.
GillisCNCatravasJD. Altered removal of vasoactive substances in the injured lung: Detection of lung microvascular injury. Ann NY Acad Sci1982; 384: 458–74.
24.
AlessandriniPMcRaeJFemanSFitzgeraldGA. Thromboxane biosynthesis and platelet function in type 1 diabetes mellitus. N Engl J Med1988; 319: 208–12.
25.
BarradasMAGillDSFonsecaVAMikhailidisDPDandonaP.Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest1988; 18: 399–404.
26.
WinocourPHKlimiukPGrennanAWeincoveC.Levels of platelet serotonin in insulin-dependent diabetes mellitus (IDDM) and systemic sclerosis. Eur J Clin Invest1987; 17: A24.
